Is Compounded Ketotifen Safe and Legal?
Compounded ketotifen is legal when prescribed by a licensed provider. It is widely used for MCAS, mast cell disorders, and allergic conditions.
Get Free Ketotifen Quotes →The Short Answer
Ketotifen is a mast cell stabilizer and H1 antihistamine. It is FDA-approved in the United States only as an ophthalmic solution (Zaditor, Alaway) for allergic conjunctivitis. Oral ketotifen is available by prescription in many countries but not commercially in the U.S. — compounding pharmacies prepare oral ketotifen capsules, liquids, and combination formulations for U.S. patients whose providers prescribe it for mast cell activation syndrome (MCAS), mastocytosis, chronic urticaria, or allergic conditions.
Who Is Eligible for Compounded Ketotifen?
- A valid prescription from a licensed U.S. healthcare provider is required.
- Commonly prescribed for MCAS, mastocytosis, chronic urticaria, asthma, allergic rhinitis, and other mast-cell-driven conditions.
- Oral ketotifen is off-label in the United States — FDA approval covers only the ophthalmic form.
- Because oral ketotifen is not commercially available in the U.S., compounding is a legitimate pathway under Section 503A.
Safety Considerations
- Drowsiness is the most common side effect and typically decreases after a few weeks of consistent use.
- Starting dose is usually low (0.5–1 mg at bedtime) and titrated up.
- Often used alongside other mast cell stabilizers (cromolyn sodium, quercetin) and antihistamines (H1 and H2 blockers).
- MCAS patients are often highly sensitive to excipients — ask the pharmacy for dye-free, filler-minimized capsule formulations.
Red Flags: What to Avoid
- Overseas websites selling oral ketotifen without a prescription to U.S. patients.
- Pharmacies that will not specify the capsule base or excipients — critical for MCAS patients.
- Providers prescribing ketotifen for weight loss or athletic use without legitimate clinical indication.
Frequently Asked Questions
Why isn't oral ketotifen commercially available in the United States?
Oral ketotifen has been approved in Canada, Europe, and many other countries for decades, but was never marketed as an oral product in the United States. The ophthalmic form is FDA-approved for allergic conjunctivitis. Because the oral product is not commercially available in the U.S., compounding pharmacies are permitted to prepare it for individual patients under Section 503A.
Is compounded ketotifen safe?
Ketotifen has been used for decades internationally with a well-established safety profile. At typical MCAS doses (1–4 mg/day), the most common side effect is drowsiness. Serious adverse effects are uncommon. As with any compounded medication, use from a licensed U.S. pharmacy under provider supervision.
Can I get ketotifen in a form other than capsules?
Yes. Compounding pharmacies prepare ketotifen as oral liquid (useful for precise micro-dosing), sublingual drops, and combination capsules with other mast cell stabilizers. MCAS patients commonly request dye-free capsules with minimal excipients.
Keep Reading
Deep dive: Full article on Ketotifen from our blog →
Pharmacy basics: 503A vs 503B pharmacies — what's the difference? →
Vetting pharmacies: How to find a reputable compounding pharmacy →
Overview: Compounded Ketotifen — overview & pricing →
Compare prices: Compare Ketotifen pricing from licensed pharmacies →
Get Free Ketotifen Quotes
Licensed U.S. compounding pharmacies. No account, no obligation. Results in 1–2 business days.